by | PRNewswire Asia
ZHUBEI, May 26, 2026 /PRNewswire/ — Precision and minimally invasive are more than technical goals—they are a pledge to uphold patient dignity. In the high-stakes realm of neurosurgery, where the brain’s complexity leaves only a millimeter of room for...
by | PRNewswire Asia
Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial dataset Leveraging large-scale, multi-center brain MRI datasets to detect key lesion biomarkers SEOUL, South Korea, May 26, 2026 /PRNewswire/ — Neurophet (Co-CEOs Jake...
by | PRNewswire Asia
SK bioscience collaborates with Colombia’s government-led US$260 million vaccine localization initiative through technology transfer and local manufacturing cooperation with state-owned pharmaceutical company VECOL This alliance enables SK bioscience to enter...
by | PRNewswire Asia
TAIPEI and SHANGHAI and SAN FRANCISCO, May 26, 2026 /PRNewswire/ — HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced the completion of...
by | PRNewswire Asia
Approval granted by South Korea’s Ministry of Food and Drug Safety (MFDS) Eptinezumab is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for the preventive treatment of migraine in adults Authorization supported by the Phase 3 SUNRISE trial...
by | PRNewswire Asia
SEOUL, South Korea, May 26, 2026 /PRNewswire/ — Sky Labs (CEO Jack ByungHwan Lee) announced on the 26th that its ring-type cuffless blood pressure monitor, ‘CART BP pro,’ has been officially integrated into the ‘2026 Korean Society of...